StrokeBrain IschemiaIncidenceCerebrovascular DisordersRisk FactorsFibrinolytic AgentsTissue Plasminogen ActivatorCerebral HemorrhageCerebral InfarctionAcute DiseaseIschemic Attack, TransientThrombolytic TherapyProspective StudiesInfarction, Middle Cerebral ArteryBrain InfarctionTreatment OutcomeTime FactorsIntracranial HemorrhagesFollow-Up StudiesCohort StudiesRetrospective StudiesIntracranial ThrombosisTomography, X-Ray ComputedIntracranial EmbolismSeverity of Illness IndexRegistriesPredictive Value of TestsCase-Control StudiesRecovery of FunctionAnticoagulantsIntracranial ArteriosclerosisRecurrenceMagnetic Resonance ImagingRiskCerebral AngiographyNeuroprotective AgentsOdds RatioComorbidityAtrial FibrillationIntracranial Arterial DiseasesBrainReperfusionRisk AssessmentCerebrovascular CirculationMagnetic Resonance AngiographyMultivariate AnalysisPlatelet Aggregation InhibitorsStroke, LacunarPrognosisProportional Hazards ModelsAge DistributionCerebral ArteriesWarfarinUnited StatesLogistic ModelsDiffusion Magnetic Resonance ImagingAspirinCerebral RevascularizationParesisAge FactorsCarotid StenosisMechanical ThrombolysisSex DistributionThrombectomyHypertensionRegression AnalysisIschemiaPrevalenceMiddle Cerebral ArteryInfarction, Anterior Cerebral ArteryEmbolismEuropean Continental Ancestry GroupNeurologic ExaminationJapanCerebral Arterial DiseasesDouble-Blind MethodNeurologyUltrasonography, Doppler, TranscranialIntracranial Embolism and ThrombosisStroke VolumeBiological MarkersInjections, Intra-ArterialRandomized Controlled Trials as TopicHospitalizationBrain EdemaEmergency Medical ServicesSecondary PreventionInjections, IntravenousDatabases, FactualDisease Models, AnimalChinaAfrican Continental Ancestry GroupSex FactorsMyocardial InfarctionGenetic Predisposition to DiseaseOutcome Assessment (Health Care)Carotid Artery DiseasesKentuckyEndarterectomy, CarotidCyclic Nucleotide Phosphodiesterases, Type 3